# Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB Trial

> **NCT07738523** · PHASE2,PHASE3 · RECRUITING · sponsor: **Hospital Universitario Getafe** · enrollment: 50 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Permanent Atrial Fibrillation
- Coffee Consumption
- Caffeine Abuse

## Interventions

- **DIETARY_SUPPLEMENT:** Dietary Caffeine Intake

## Key facts

- **NCT ID:** NCT07738523
- **Lead sponsor:** Hospital Universitario Getafe
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-27
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-03-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07738523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07738523, "Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07738523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*